Dr. Daniel B. Roth joined NJRetina in 2000. Dr. Roth graduated from Yeshiva University in New York City, where he was valedictorian. He received his MD from the Yale University School of Medicine.
Dr. Roth completed his residency in ophthalmology at the Bascom Palmer Eye Institute in Miami. He was accepted into the Alpha Omega Alpha Honor Society and received awards by the Fight for Sight Research Foundation, Howard Hughes Research Institute, and ARVO (Association for Research in Vision and Ophthalmology). Dr. Roth completed his fellowship training in vitreoretinal disease and surgery at the Cleveland Clinic.
Dr. Roth is a Clinical Associate Professor in Ophthalmology at the University of Medicine and Dentistry of New Jersey/ Rutgers Robert Wood Johnson Medical School. He is on the medical staff of Robert Wood Johnson University Hospital, New Brunswick, and Monmouth Medical Center Southern campus (MMCSC), Lakewood, NJ.
Dr. Roth is the Principal Investigator (PI) for multiple national and international clinical trials and is a member of the Committee for Continuing Medical Education at the medical school. Dr. Roth has been elected by his peers for inclusion in Top Doctors and Best Doctors of America and has received awards for scientific achievement from the AAO (American Academy of Ophthalmology) and ASRS (American Society of Retinal Specialists). Dr. Roth has published more than 80 papers in peer-reviewed literature, as well as numerous articles, textbook chapters, and scientific abstracts. He has researched, published, and lectured at national meetings on numerous topics in ophthalmology, including age-related macular degeneration, macular hole repair, endophthalmitis, cytomegalovirus retinitis, choroidal melanoma, submacular surgery, retinal vascular occlusion, retinopathy of prematurity, and ocular trauma.
Dr. Roth serves as a manuscript referee for Ophthalmology, the Journal of the American Academy of Ophthalmology, Retina, The Journal of Retinal and Vitreous Diseases, American Journal of Ophthalmology, Journal of Ocular Pharmacology and Therapeutics and the British Journal of Ophthalmology. Dr. Roth has developed innovative approaches to treating retinal diseases and is very active in teaching and mentoring medical students.
The following ratings and comments are based on verified patient experiences collected by an independent third-party survey vendor after each patient visit and reflect each patient's own views and opinions.